Magnetic Resonance Imaging Biomarkers of Bone and Soft Tissue Tumors.
Semin Musculoskelet Radiol
; 28(1): 39-48, 2024 Feb.
Article
em En
| MEDLINE
| ID: mdl-38330969
ABSTRACT
Magnetic resonance imaging (MRI) is essential in the management of musculoskeletal (MSK) tumors. This review delves into the diverse MRI modalities, focusing on anatomical, functional, and metabolic sequences that provide essential biomarkers for tumor detection, characterization, disease extent determination, and assessment of treatment response. MRI's multimodal capabilities offer a range of biomarkers that enhance MSK tumor evaluation, aiding in better patient management.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias de Tecidos Moles
/
Doenças Musculoesqueléticas
Limite:
Humans
Idioma:
En
Revista:
Semin Musculoskelet Radiol
Assunto da revista:
FISIOLOGIA
/
ORTOPEDIA
/
RADIOLOGIA
Ano de publicação:
2024
Tipo de documento:
Article